The return from pharmaceutical innovation has seen a steady decline over the past few decades. Sales per asset continues to grow at a slower pace compared to the cost of discovery, development and manufacturing of drugs. Artificial intelligen...

Contact Us
X
  • I agree to receive updates on the latest industry trends, products and services from Netscribes.
  • We respect your right to data privacy and security. You may unsubscribe from our communications at any time. For more information, check out our Privacy Policy.